Results 41 to 50 of about 11,901 (167)
MOESM2 of Efficacy of artemetherâ lumefantrine, artesunateâ amodiaquine, and dihydroartemisininâ piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015
, 2017 Additional file 2. Lengths of neutral microsatellite markers for late treatment failures and randomly chosen treatment successes, Angola therapeutic efficacy monitoring, 2015.Plucinski, Mateusz, Dimbu, Pedro, Macaia, Aleixo, Ferreira, Carolina, Samutondo, Claudete, Quivinja, Joltim, Afonso, MarĂlia, Kiniffo, Richard, Mbounga, Eliane, Kelley, Julia, Patel, Dhruviben, He, Yun, Talundzic, Eldin, Garrett, Denise, Halsey, Eric, Udhayakumar, Venkatachalam, Ringwald, Pascal, Fortes, Filomeno +17 moreopenaire +1 more sourcePolymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. [PDF]
, 2014 Adequate clinical and parasitologic cure by artemisinin combination therapies relies on the artemisinin component and the partner drug. Polymorphisms in the Plasmodium falciparum chloroquine resistance transporter (pfcrt) and P.Kamugisha, Erasmus, Piola, Patrice, Faucher, Jean-François, El-Sayed, Badria, Houzé, Sandrine, Somé, A Fabrice, Sutherland, Colin, Checchi, Francesco, Plowe, Christopher, V, Sutherland, Colin J, Otienoburu, Sabina Dahlström, Berens-Riha, Nicole, Grivoyannis, Anastasia, Davis, Timothy ME, Björkman, Anders, Asaq Molecular Marker Study Group, Rosenthal, Philip, Eyase, Frederick, Malmberg, Maja, Kariuki, Simon, Mårtensson, Andreas,, Hamour, Sally, Ogutu, Bernhards, Davis, Timothy, Wong, Rina, Sibley, Carol Hopkins, Gadalla, Nahla B, Ngasala, Billy, Ménard, Didier, Oguike, Mary, Venkatesan, Meera, Arze, Cesar, Djimdé, Abdoulaye A, Baliraine, Frederick N, Fröberg, Gabrielle, Ursing, Johan, LeBras, Jacques, Desai, Meghna, Mårtensson, Andreas, Ouédraogo, Jean-Bosco, El-Sayed, Badria B, Mwai, Leah, Thwing, Julie, Kironde, Fred, Djimde, Abdoulaye, Price, Ric, Dorsey, Grant, Johnson, Jacob, Guérin, Philippe, Somé, A. Fabrice, Oguike, Alexis Nzila Mary, LeBras, Poul-Erik Kofoed Jacques, Moriera, Clarissa, Kiechel, Jean-René, Kofoed, Poul-Erik, Dahal, Prabin, Nsanzabana, Christian, Nzila, Alexis, Wong, Rina PM, Rosenthal, Philip J, Ademowo, George, Falade, Catherine, Nsobya, Samuel L, Schramm, Birgit, Zongo, Issaka, Gadalla, Nahla, Wong, Rina P M, Plowe, Christopher V, Eshetu, Teferi, Davis, Timothy M E, Dhorda, Meghna Desai Mehul, Plowe, Christopher,, Rombo, Lars,, Dhorda, Mehul, Stepniewska, Kasia, Adam, Ishag, Price, Ric N, Borrmann, Steffen, Nosten, Francois, Rombo, Lars, Baliraine, Frederick, Zeynudin, Ahmed, Nsobya, Samuel +82 morecore +1 more sourceEfficacy of artemether-lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change
The Pan African Medical Journal, 2020 INTRODUCTION: Artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) are the first line therapy of uncomplicated malaria in Burkina Faso. We assessed the treatment efficacy, tolerability of these drugs 11 years following its adoption as first ...Issaka Zongo, Yves Daniel Compaoré, Frédéric Nikiéma, Moussa Zongo, Nouhoun Barry, Fabrice Anyirékun Somé, Naomie Kaboré, Jean Bosco Ouédraogo +7 moredoaj +1 more sourceMOESM1 of Adherence to treatment with artemetherâ lumefantrine or amodiaquineâ artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial
, 2018 Additional file 1:Table S1.Banek, Kristin, Webb, Emily, Smith, Samuel, Chandramohan, Daniel, Staedke, Sarah +4 moreopenaire +1 more sourceAdherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. [PDF]
, 2010 \ud
\ud
Controlled clinical trials have shown that a six-dose regimen of artemether-lumefantrine (AL) therapy for uncomplicated Plasmodium falciparum malaria results in cure rates >95% with good tolerability.Abdunoor M Kabanywanyi, Nathan Mulure, King'eng'ena, Said, Kabanywanyi Abdunoor M, Mulure, Nathan, Christian Lengeler, Prudensiana Kasim, Schlienger, Raymond, Raymond Schlienger, King'eng'ena S.,, Lengeler Christian, Blaise Genton, Mulure, N., Lengeler, C., Genton, Blaise, Lengeler, Christian, Genton Blaise, Kasim Prudensiana, Kasim, Prudensiana, Kabanywanyi, A. M., King'eng'ena Said, Schlienger Raymond, Mulure Nathan, Kabanywanyi, Abdunoor M, Schlienger, R., Said King'eng'ena, Genton, B., Kasim, P. +27 morecore +1 more sourcePyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial
Malaria Journal, 2012 Background Children are most vulnerable to malaria. A pyronaridine-artesunate pediatric granule formulation is being developed for the treatment of uncomplicated Plasmodium falciparum malaria. Methods This phase III, multi-center, comparative, open-label,Kayentao Kassoum, Doumbo Ogobara K, Pénali Louis K, Offianan André T, Bhatt Kirana M, Kimani Joshua, Tshefu Antoinette K, Kokolomami Jack HT, Ramharter Michael, de Salazar Pablo Martinez, Tiono Alfred B, Ouédraogo Alphonse, Bustos Maria Dorina G, Quicho Frederick, Borghini-Fuhrer Isabelle, Duparc Stephan, Shin Chang-Sik, Fleckenstein Lawrence +17 moredoaj +1 more sourceMOESM2 of A case of blackwater fever with persistent Plasmodium falciparum parasitaemia detected by PCR after artemetherâ lumefantrine treatment
, 2018 Additional file 2. Results of gametocyte-specific PCRsâ assays.Huggan, Paul, Ng, Chin, Ho, Jennifer, Lin, Raymond, Chavatte, Jean-Marc +4 moreopenaire +1 more sourceArtemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. [PDF]
, 2007 OBJECTIVES: To compare the efficacy and safety of artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) for treating uncomplicated falciparum malaria in Uganda. DESIGN: Randomized single-blinded clinical trial.Staedke Sarah G, Wabwire-Mangen, F, Yeka Adoke, Rwakimari, JB, Dorsey, Grant, Rwakimari John B, Nosten François, Talisuna, Ambrose O, Dorsey Grant, Kamya, MR, Greenhouse Bryan, Rosenthal, PJ, Greenhouse, B, Rosenthal Philip J, Staedke, SG, Nosten, F, Lugemwa, Myers, Rosenthal, Philip J, Yeka, Adoke, Dorsey, G, Staedke, Sarah G, Greenhouse, Bryan, Rwakimari, John B, Bukirwa, H, Bukirwa, Hasifa, Lugemwa, M, Kamya Moses R, Lugemwa Myers, Kamya, Moses R, Bukirwa Hasifa, Wabwire-Mangen Fred, Talisuna Ambrose O, Wabwire-Mangen, Fred, Talisuna, AO, Nosten, François, Yeka, A +35 morecore +1 more sourceMOESM2 of Efficacy of artemetherâ lumefantrine and dihydroartemisininâ piperaquine for the treatment of uncomplicated malaria in Papua New Guinea
, 2018 Additional file 2: Figure S1. Haemoglobin concentration.Tavul, Livingstone, Hetzel, Manuel, Teliki, Albina, Dorish Walsh, Benson Kiniboro, Rare, Lawrence, Pulford, Justin, Siba, Peter, Karl, Stephan, Makita, Leo, Robinson, Leanne, Kattenberg, Johanna, Laman, Moses, Gilchrist Oswyn, Mueller, Ivo +14 moreopenaire +1 more source
